Jacksonville emerges as breakthrough hub for advanced medical procedures (Courtesy of the Jacksonville Business Journal) — Jacksonville is fast becoming a proving ground for medical innovation.
Local providers are among the first in Northeast Florida to adopt next-generation treatments.
From new cataract technology promising life without glasses to dual-procedure breakthroughs reducing stroke risk, the city’s hospitals and specialty practices are pushing the boundaries of what’s possible in patient care.
Florida Eye Specialists and Ascension St. Vincent’s Riverside are leading that charge, introducing technologies that not only improve outcomes, experts say, but also solidify Jacksonville’s status as a regional center for advanced medicine and surgical innovation.
Redefining heart care at St. Vincent’s
That spirit of innovation is clear at St. Vincent’s Riverside, where physicians are redefining heart care. The hospital was among the first to adopt a dual-procedure approach to stroke prevention, establishing itself as a regional leader in advanced cardiovascular treatment.
It recently completed its 1,000th pulse field ablation procedure using a new non-thermal system developed by Boston Scientific, called FARAPULSE.
Unlike traditional methods, it uses rapid electrical pulses to selectively target heart tissue — a safer option to restore normal heart rhythm, according to a statement.
This method is one of the newest and “most promising” advances in treatment of atrial fibrillation, according to St. Vincent’s, which only recently was approved for widespread clinical use. AFib increases a person’s risk for stroke and was associated with an approximately fivefold increase of ischemic stroke, according to the CDC.
“This is an exciting step forward in the care we can provide to patients living with AFib here in Jacksonville,” said Dr. Anthony Magnano, a cardiologist at St. Vincent’s Riverside. “By combining these groundbreaking procedures, we can both restore heart rhythm and reduce stroke risk in a way that is less stressful and invasive for our patients.”
Aside from being among the first with the Boston Scientific-developed system, the Riverside hospital is also among the first to combine it with a Watchman device. It reduces stroke risk for AFib patients by sealing off the left atrial appendage, eliminating the need for long-term blood thinners, according to a spokesperson.
That means less time under anesthesia, fewer procedures and a faster, safer recovery for patients.
A clearer future for cataract patients
Elsewhere in the city, the region’s largest multi-specialty eye practice is offering PanOptix lenses.
“This technology represents the next evolution in premium cataract care,” said Dr. Kathryn Freidl, who performed the region’s first implantation this month. “It offers sharper vision, increased reliability and a broader range of candidates who can benefit from life without glasses after cataract surgery.”
FLORIDA EYE SPECIALISTS
It’s the newest advancement in cataract surgery, according to the company, designed to deliver a full range of vision. Building upon the success of the original PanOptix lens, this next-generation features a proprietary material and enhanced haptic design to provide more consistent visual outcomes and an optimized surgical experience.
The technology is helping patients reduce or even eliminate their dependence on glasses, according to a spokesperson.
Together, leaders at St. Vincent’s Riverside and Florida Eye Specialists underscored these technologies as advancements in Jacksonville’s emergence as a regional hub for cutting-edge medical care — one where next-generation technologies drive better outcomes and position local providers as leaders in the future of health care.